What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?

被引：0
|
作者：
Jongbeom Shin
Sung Min Kong
Gyeol Seong
Young-Ho Kim
机构：
[1] Samsung Medical Center,Department of Internal Medicine
[2] Sungkyunkwan University School of Medicine,undefined
来源：
International Journal of Colorectal Disease | 2020年 / 35卷
关键词：
CRP; Ulcerative colitis; Clinical remission; Endoscopic remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2249 / 2255
页数：6
相关论文
共 50 条
  • [21] OLSALAZINE IN MAINTENANCE OF CLINICAL REMISSION IN PATIENTS WITH ULCERATIVE-COLITIS
    WRIGHT, JP
    OKEEFE, EA
    CUMING, L
    JASKIEWICZ, K
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1837 - 1842
  • [22] Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?
    Chang, Ji Young
    Cheon, Jae Hee
    Park, Yehyun
    Park, Soo Jung
    Kim, Tae-Il
    Kim, Won-Ho
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (11) : 3041 - 3048
  • [23] Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?
    Ji Young Chang
    Jae Hee Cheon
    Yehyun Park
    Soo Jung Park
    Tae-Il Kim
    Won-Ho Kim
    Digestive Diseases and Sciences, 2018, 63 : 3041 - 3048
  • [24] End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis
    Wong, Emily Chu Lee
    Hasan, Badar
    Dulai, Parambir S.
    Marshall, John K.
    Reinisch, Walter
    Narula, Neeraj
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (01) : 7 - 14
  • [25] Dose medical acceleration improve outcomes in ulcerative colitis patients who are in clinical remission but have endoscopic inflammation?
    Chang, Ji Young
    Cheon, Jae Hee
    Park, Yehyun
    Park, Soo Jung
    Kim, Tae-Il
    Kim, Won-Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 85 - 85
  • [26] Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab
    Chaemsupaphan, Thanaboon
    Pudipeddi, Aviv
    Lin, Huiyu
    Paramsothy, Sudarshan
    Kariyawasam, Viraj
    Kermeen, Melissa
    Leong, Rupert W.
    CROHNS & COLITIS 360, 2025, 7 (01)
  • [27] What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?
    Travis, S
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (12): : 564 - 565
  • [28] Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study
    Fukuba, Nobuhiko
    Ishihara, Shunji
    Tada, Yasumasa
    Oshima, Naoki
    Moriyama, Ichiro
    Yuki, Takafumi
    Kawashima, Kousaku
    Kushiyama, Yoshinori
    Fujishiro, Hirofumi
    Kinoshita, Yoshikazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 674 - 680
  • [29] Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
    Malvao, Ludimilla dos Reis
    Madi, Kalil
    Esberard, Barbara Cathala
    de Amorim, Renata Fernandes
    Silva, Kelly dos Santos
    Silva, Katia Farias e
    de Souza, Heitor Siffert Pereira
    Carvalho, Ana Teresa Pugas
    MEDICINE, 2021, 100 (03) : E24058
  • [30] Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis
    Oh, Chang Kyo
    Lee, Han Hee
    Kim, Jin Su
    Lee, Bo-In
    Cho, Young-Seok
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
12345